Aurinia Pharm Ord (AUPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 77,705 | 77,114 | 73,468 | 70,008 | 62,465 |
| Cost of Goods | 6,505 | 8,799 | 8,177 | 7,115 | 8,574 |
| Gross Profit | 71,200 | 68,315 | 65,291 | 62,893 | 53,891 |
| Operating Expenses | 30,004 | 40,949 | 34,794 | 33,679 | 28,189 |
| Operating Income | 41,701 | 28,165 | 30,674 | 29,329 | 26,276 |
| Interest Expense | 1,012 | 1,047 | 1,099 | 1,117 | 1,067 |
| Other Income | 3,236 | 8,572 | 2,387 | -6,056 | -860 |
| Pre-tax Income | 43,925 | 35,690 | 31,962 | 22,156 | 24,349 |
| Income Tax | 9,570 | -175,104 | 411 | 643 | 1,005 |
| Net Income Continuous | 34,355 | 210,794 | 31,551 | 21,513 | 23,344 |
| Net Income | $34,355 | $210,794 | $31,551 | $21,513 | $23,344 |
| EPS Basic Total Ops | 0.26 | 1.57 | 0.24 | 0.16 | 0.17 |
| EPS Basic Continuous Ops | 0.26 | 1.57 | 0.24 | 0.16 | 0.17 |
| EPS Diluted Total Ops | 0.25 | 1.52 | 0.23 | 0.16 | 0.16 |
| EPS Diluted Continuous Ops | 0.25 | 1.52 | 0.23 | 0.16 | 0.16 |
| EPS Diluted Before Non-Recurring Items | 0.25 | 0.26 | 0.23 | 0.16 | 0.16 |
| EBITDA(a) | $46,517 | $33,029 | $35,539 | $34,193 | $31,132 |